April’s Ashtons Pharmacy News is now available

 In Pharmacy Information, Regulations and Standards

The latest version of Ashtons Pharmacy News is now available. Topics include –

Our feature article is about the disposal of unwanted medication and management of medical waste. This can pose a problem to healthcare organisations as there are many regulations that must be adhered to, with severe penalties for non-compliance. We look at the requirements for disposing of unwanted medication safely and ensure you are familiar with the different medical waste storage requirements.

We recently conducted our Annual Customer Survey to see how we were performing from our clients’ perspective and to get some feedback as to what we could do better. We have provided a snapshot of the statistics we received from the survey to give you an idea of the overall satisfaction levels of our service.

The Ashtons Live View System is helping to reduce prescribing and medication errors. Ashtons pharmacists visit hospitals providing clinical input, submitting their reports electronically through this system and we have collated some significant statistics.

There is a national supply problem with Hyoscine Hydrobromide tablets, Kwells®, and the resulting shortage of stock will continue for several months. We recommend some alternative treatments that could be used to treat hypersalivation. We have also provided a reminder to consider using sunscreen products for inpatients when they go outside in sunny conditions to provide protection from sunburn and skin sensitivity reactions.

Finally, if you or any of your colleagues would like to subscribe free of charge to Ashtons Pharmacy News so that you don’t miss out, please provide us with your email address and we will ensure you receive your own electronic copy every quarter. Please contact us on 0345 222 3550 or email us at customerservice@ahps.co.uk.

You can download the April Version of the Ashtons Pharmacy News by clicking here.

Recent Posts

Start typing and press Enter to search

KwellsNeuroleptic Malignant Syndrome